Ulf Arne Wiinberg

Ulf Arne Wiinberg

Directeur/Membre du Conseil chez UCB

Fortune : 2 M $ au 31/05/2026

67 ans
Health Technology
Producer Manufacturing
Commercial Services

Profil

Ulf Arne Wiinberg is President & Chief Executive Officer at X-Vax Technology, Inc. and Chairman & Chief Executive Officer at Ulf Wiinberg Consult & Invest AB. Holds the position of Chairman at Sigrid Therapeutics AB. Serves as Director at the International Federation of Pharmaceutical Manufacturers, European Federation of Pharmaceutical Industries & Assns, Lexington Group, Inc., Wallon Institute for Life Lead Sciences, and UCB Pharma AB. Independent Director at UCB SA since 2016, Alfa Laval AB since 2013, MiNK Therapeutics, Inc. since 2017, and Director at AgenTus Therapeutics SA since 2018.
Formerly President & Chief Executive Officer at H.
Lundbeck A from 2008 to 2014.
Chairman at Hansa Biopharma AB from 2018 to 2022.
Chairman & Manager-Human Resources at Trialbee AB. Chairman at Avillion LLP and Lund Science AB. Director-Europe, Middle East & Africa Region at Wyeth Pharmaceuticals LLC.
Managing Director at John Wyeth & Brother Ltd. Director at Pharmaceutical Research & Manufacturers of America, The European Medicines Agency, and Nestle Health Science SA. Independent Director at Agenus, Inc. from 2016 to 2024.
President-Europe, Middle East & Africa Region at Wyeth LLC from 2002 to 2008.
President at Wyeth Consumer Healthcare, Inc. from 2002 to 2005.
President at Wyeth BioPharma.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 20 000 ( 0 % ) 1 M $ 31/05/2026
01/06/2026 50 480 ( 1,01 % ) 615 856 $ 31/05/2026

Postes actifs de Ulf Arne Wiinberg

SociétésPosteDébut
ALFA LAVAL AB Directeur/Membre du Conseil 23/04/2013
UCB Directeur/Membre du Conseil 28/04/2016
MINK THERAPEUTICS, INC. Directeur/Membre du Conseil 01/07/2017
UCB Pharma AB
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur Général -
Wallon Institute for Life Lead Sciences
Directeur/Membre du Conseil -
Directeur Général -
Président -
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Ulf Arne Wiinberg

SociétésPosteFin
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ulf Arne Wiinberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Distribution Services

Government

Wallon Institute for Life Lead Sciences

Health Technology

Lund Science AB

Technology Services

Health Technology

Health Technology

UCB Pharma AB

Health Technology

Finance

Health Technology

AgenTus Therapeutics SA

  1. Bourse
  2. Insiders
  3. Ulf Arne Wiinberg
🔇